You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 87 No. 4, APRIL 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ALTERATIONS IN THE BACTERIAL FLORA OF THE THROAT DURING ORAL THERAPY WITH AUREOMYCIN

MANSON MEADS, M.D.; WALLACE P. ROWE, M.D.; NANCY M. HASLAM, B.S.

AMA Arch Intern Med. 1951;87(4):533-540.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE BACTERIAL flora of the normal nasopharynx may be altered significantly during the therapeutic administration of sulfadiazine,1 penicillin2 or streptomycin.3 Usually these changes are specific and selective, so that species of organisms which are highly susceptible to the drug are eliminated rapidly. More resistant groups of bacteria, which may be present in small numbers before therapy or may enter after therapy is begun, then multiply and become the predominant organisms during the first week of treatment. If these relatively drug-fast organisms are pathogenic, they may initiate a new bacterial infection in the patient during the course of treatment for the primary disease.4 Furthermore, these strains may be transmitted to others, causing infections that require different antibacterial drugs for treatment.5

Studies of the effect of aureomycin on the normal flora of the body have been limited to the micro-organisms in the gastrointestinal6 and genital tracts.7 Collins, Gocke and Finland,8 . . . [Full Text PDF of this Article]


Author Affiliations

WINSTON-SALEM, N. C.

From the Department of Internal Medicine of the Bowman Gray School of Medicine of Wake Forest College.


Footnotes

This investigation was supported (in part) by a research grant from the National Institutes of Health, United States Public Health Service.

The aureomycin and penicillin used in this study were supplied by Lederle Laboratories Division. American Cyanamid Company Pearl River. N. Y.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.